Coming at cancer immunotherapy through macrophages
It started about five years ago, with a simple question: if T-cells can be activated to fight cancer, “why only do T-cells? What other ways are there of advancing immune responses in cancer?”
BioCanRx and Partners New Project Funding Announcement
BioCanRx and its partners today announce $1,917,833 in funding for two collaborative research projects and the second-stage funding of a current Catalyst project led by Dr. Simon Turcotte.
World Cancer Day 2018
Cancer is a disease that knows no boundaries. It is a leading cause of death worldwide, responsible for 8.8 million deaths per year. The disease is one of the biggest health challenges facing Canadians: 2 in every 5 of us will face a cancer diagnosis in our lifetime.